Vantage Investment Partners, LLC Novo Nordisk A S Transaction History
Vantage Investment Partners, LLC
- $1.19 Billion
- Q3 2024
A detailed history of Vantage Investment Partners, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Vantage Investment Partners, LLC holds 428,797 shares of NVO stock, worth $34.7 Million. This represents 4.29% of its overall portfolio holdings.
Number of Shares
428,797
Previous 534,771
19.82%
Holding current value
$34.7 Million
Previous $76.3 Million
33.11%
% of portfolio
4.29%
Previous 6.92%
Shares
10 transactions
Others Institutions Holding NVO
# of Institutions
1,918Shares Held
318MCall Options Held
5.49MPut Options Held
7.78M-
Jennison Associates LLC20.2MShares$1.64 Billion1.5% of portfolio
-
Morgan Stanley New York, NY14.4MShares$1.16 Billion0.13% of portfolio
-
Bank Of America Corp Charlotte, NC14.3MShares$1.16 Billion0.14% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa13.3MShares$1.08 Billion0.65% of portfolio
-
Fayez Sarofim & CO Houston, TX12.2MShares$990 Million3.76% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $183B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...